D Liénard
- Immunology top 2%
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 5
- Oncology top 5%
- Cutaneous Melanoma Detection and Management 7
- Immunology and Allergy top 5%
- Molecular Biology top 10%
- vaccines and immunoinformatics approaches 3
- Melanoma and MAPK Pathways 3
- Cancer Research top 10%
-
- Sarcoma Diagnosis and Treatment 4
-
- Virus-based gene therapy research 4
-
- Ultrasound and Hyperthermia Applications 4
- Co-authors
- Patricia EwalenkoFerdy J. LejeuneDonata RimoldiNathalie RenardPedro RomeroJ C CerottiniLars E. FrenchThierry Bornand
- Journals
- Melanoma Research (2 papers)European Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwitzerlandBelgiumNetherlands
In The Last Decade
D Liénard
20 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Immunology 1.1k
- Oncology 861
- Immunology and Allergy 109
- Molecular Biology 978
- Cancer Research 211
Countries citing papers authored by D Liénard
This map shows the geographic impact of D Liénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Liénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Liénard more than expected).
Fields of papers citing papers by D Liénard
This network shows the impact of papers produced by D Liénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Liénard. The network helps show where D Liénard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D Liénard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 37 | |
| 2 | 2007 | 21 | |
| 3 | 2006 | 14 | |
| 4 | Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma. | 2006 | 11 |
| 5 | 2004 | 1 | |
| 6 | 2004 | 85 | |
| 7 | Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma. | 2001 | 65 |
| 8 | 2000 | 5 | |
| 9 | Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. | 1999 | 63 |
| 10 | Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas. | 1997 | 28 |
| 11 | Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. | 1997 | 52 |
| 12 | 1997 | 2 | |
| 13 | Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escapebreakdown → | 1996 | 1052 |
| 14 | Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results. | 1995 | 20 |
| 15 | Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. | 1994 | 37 |
| 16 | Physiological and pharmacokinetics parameters in isolation perfusion of the limbs. | 1994 | 2 |
| 17 | 1993 | 10 | |
| 18 | High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.breakdown → | 1992 | 571 |
| 19 | Assessment of the haematocrit method for dosimetry of cytostatics in isolation perfusion | 1989 | 7 |
| 20 | Results of 206 isolated limb perfusions for malignant melanoma. | 1989 | 36 |
About D Liénard
D Liénard is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 20 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cutaneous Melanoma Detection and Management (7 papers), T-cell and B-cell Immunology (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Virus-based gene therapy research (4 papers), Ultrasound and Hyperthermia Applications (4 papers), vaccines and immunoinformatics approaches (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (861 citations) and Immunology and Allergy (109 citations). D Liénard has collaborated with scholars based in Switzerland, Belgium and Netherlands. Frequent co-authors include Patricia Ewalenko, Ferdy J. Lejeune, Donata Rimoldi, Nathalie Renard, Pedro Romero, J C Cerottini, Lars E. French, Thierry Bornand, Michael Schröter and J Tschopp. Their work appears in journals such as Melanoma Research, European Journal of Cancer, Journal of Clinical Oncology, Journal of Surgical Oncology and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.